ÀÚ·á¹®ÀÇ:02-703-5000/info@oic.co.kr        
À¯ÀüÀÚ Áúº´&Ä¡·á ¹é½Å ³­¿¬Á¦ IT ¹× »çÀ̹ö º¸¾È ȯ°æ¹®Á¦ ¹Ì¿ë/¼ºÇü ÀÚµ¿Â÷ À¶ÇÕ/¹Ì·¡»ê¾÷ ÀçÈ°¿ë Áö¿À¸Åƽ½º/ÅÚ·¹¸Åƽ½º ž翭 ¿¡³ÊÁö ¹ÙÀÌ¿À¸ÞÄ«Æ®·Î´Ð½º Á¢ÂøÁ¦&Á¡ÂøÁ¦ ÄÚÆà ¿þ¾î·¯ºí ÀåÄ¡,±â±â »ö¼Ò,¾È·á,¿°·á »ýÈ­ÇÐ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¼ö·Â¹ßÀü ±×¸°¿¬·á/¹ÙÀÌ¿À¿¬·á üÁß°ü¸®/ºñ¸¸Ä¡·á dz·Â ¿¡³ÊÁö Àü·Â¹ÝµµÃ¼ ÀÇ¾à °ü·Ã ¹«¿ª,Àü·« ½º¸¶Æ®È¨&½º¸¶Æ®ºôµù Æó±â¹° ó¸® ³ÃÀå°í È­ÇÐÇ° ±ÔÁ¦ Ä«¸Þ¶ó ¾ËÃ÷ÇÏÀ̸Ó/Ä¡¸Å/ÆÄŲ½¼ ·Îº¿ »ê¾÷ ¼¾¼­ Ä¡°ú¿ë ±â±â ¾È°ú¿ë ±â±â °íÁÖÆÄ, ¹«¼± ÁÖÆļö Flexible display ÀǾàÇ° Á¦Á¶±â¾÷ ÀÇ·á¿ë/¹ÙÀÌ¿À ÀÎÆ÷¸Åƽ½º »ýüÀç·á/»ýüÈí¼ö »ýü¸ð¹æ/»ýŸð¹æ ¹ÙÀÌ¿À¸â½º/¹ÙÀÌ¿À³ª³ë
all of these words any of these words
 
    Àΰ£ÀÇ °¨¼º¿¡ °¡±î¿î...
    ¹Ì·¡ ¿¹Ãø¿¡ ÀÇÇÑ ¿¬...
    ÀÚµ¿Â÷ ½Ç³»ÀÇ Á¤¼÷¼º...
    ±Ý¼Ó ³ª³ë ÀÔÀÚ, ¹Ì¸³...
    ** ÇÒÀÎÀÚ·á Àüü
 
***************************
Àüü  |  ¿µ¹®¸¸  |  ÀϹ®¸¸      ¹ÙÀÌ¿ÀÀǾà
(ÁÖÁ¦¿Í °ü·Ã¾øÀ¸¸é "»õ·Î°íħ" ÇØÁÖ¼¼¿ä)
 
ÀÚ·á¸í   °¡°Ý ¹ßÇàÀÏ
Single-Use Technologies for Biopharmaceuticals: Global Markets(¹ÙÀÌ¿À ÀǾàÇ°ÀÇ SUT(½Ì±ÛÀ¯Áî ±â¼ú) : Àü¼¼°è ½ÃÀå)    $ 5,500   2013-01
Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness(¹ÙÀÌ¿ÀÀǾàÇ°ÀÇ ´Ù¿î½ºÆ®¸² °øÁ¤)    $ 3,500   2012-11
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth(¹ÙÀÌ¿À ÀǾàÇ° Á¦Á¶ : Àεµ, Áß±¹, Çѱ¹)    $ 3,500   2012-10
Æú¸®Æä³î:¾à¿ë ½Ä¹° ¹× ½ÄÇ°ÀÇ ±â´É¼º ¼ººÐ    ¡Í 68,000   2012-10
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market(Á¦¾à ½ÃÀåÀÇ °¡¼ÓÈ­)    $ 3,500   2012-09
·¹½ºº£¶óÆ®·ÑÀÇ ±âÃÊ¿Í ÀÀ¿ë    ¡Í 66,000   2012-09
Biologics in the Emerging Markets - Ripe For Realization of the Commercial Potential - But Hurdles Still to Overcome(½ÅÈï ½ÃÀåÀÇ »ý¹°ÇÐÀû ¾à¹°)    $ 3,900   2012-09
Global Biopharmaceuticals Market 2011-2015(Àü¼¼°è ¹ÙÀÌ¿ÀÀǾàÇ° ½ÃÀå )    $ 2,000   2012-07
Top 200 Biopharmaceutical Companies (Global)(Àü¼¼°è ÁÖ¿ä 200 ¹ÙÀÌ¿À ÀǾàÇ° ±â¾÷)    ¡Ì 950   2012-07
Top 200 Medicinal & Botanical Pharmaceutical Manufacturers (European)(À¯·´ÀÇ ÁÖ¿ä 200 ¾à¿ë ¹× ½Ä¹° ÀǾàÇ° Á¦Á¶»ç)    ¡Ì 800   2012-07
Global Biotech API Market Analysis(Àü¼¼°è ¹ÙÀÌ¿ÀÅØ API ½ÃÀå ºÐ¼®)    $ 1,000   2012-06
Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth(½ÅÈï ½ÃÀåÀÇ »ý¹°Á¦Á¦ Àü·«)    $ 3,500   2012-06
Biotechnology Reagents - A Global Strategic Business Report (Àü¼¼°è ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ½Ã¾à ½ÃÀ嵿Çâ ¹× ±â¾÷ ÇÁ·ÎÇÊ)    $ 4,500   2012-04
¾à¿ë ½ÄÇ°ÀÇ °³¹ß II ¡ª¾à¿ë¡¤À¯¿ë ½Ä¹°ÀÇ ±â´É¼º ½ÄÇ° ¼ÒÀç¿¡ÀÇ ÀÀ¿ë    ¡Í 70,000   2012-04
¹ÙÀÌ¿À ÀǾàÇ° Á¦Á¶ÀÇ È¿À²È­¿Í »ý»ê±âÀçÀÇ °³¹ß    ¡Í 68,000   2012-04
      

  11  12  13  14  15  16  17  18  
 

 

±Ý¿¬Ä¡·áÁ¦
Èñ±ÍÁúȯ
Å°³ª¾ÆÁ¦
Á¦³×¸¯ ÀǾàÇ°
¹æ»ç¼º ÀǾàÇ°
ó¹æ¾à
¹ÙÀÌ¿ÀÀǾà
»ý¾à,Çѹæ,¾àÃÊ
ÁÖ»çÁ¦
ÀÇ·á¿ë ¸¶¾à ¹× ´ë¸¶
Åë½Å
ÀüÀÚ
Áß°ø¾÷
Á¦¾à
È­ÇÐ
ÀÇÇÐ
ȯ°æ
½ÄÇ°
¹æÀ§»ê¾÷
±âŸ
   .
   -¿¬±¸°³¹ß¸®´õ .
   -CosmeticStage .
   -PharmStage .
   -MaterialStage .
   -Â÷Àç Technology .
   .
   .
   .
ID(email)
Password
ºñ¹Ð¹øÈ£ ºÐ½Ç ȸ¿ø°¡ÀÔ
È­Æó
ȯÀ²
(ÇϳªÀºÇà ¼Û±Ýº¸³¾¶§)
¹Ì±¹USD
\ 1,397.60
ÀϺ»JPY
\ 9.0396
À¯·ÎEUR
\ 1,487.19
¿µ±¹GBP
\ 1,737.29

Copyright¨Ï2024 OIC(Overseas Information Center) All Rights Reserved.
04373 ¼­¿ï½Ã ¿ë»ê±¸ ÀÌÃÌ·Î 1(GSÇÑ°­¿¡Å¬¶óÆ®) 1121È£
E_mail : info@oic.co.kr Tel: 02-703-5000 Fax: 02-714-1109 /°³ÀÎÁ¤º¸ Ãë±Þ¹æħ